1. A high affinity recombinant antibody to the human EphA3 receptor with enhanced ADCC activity. (December 2014) Authors: Tomasevic, Nenad; Luehrsen, Kenneth; Baer, Mark; Palath, Varghese; Martinez, David; Williams, Jason; Yi, Christina; Sujatha-Bhaskar, Swathi; Lanke, Rohini; Leung, John; Ching, Wendy; Lee, Andreia; Bai, Lu; Yarranton, Geoffrey; Bebbington, Christopher Journal: Growth factors Issue: Volume 32:Number 6(2014:Dec.) Page Start: 223 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Anti‐PcrV antibody in cystic fibrosis: A novel approach targeting Pseudomonas aeruginosa airway infection. Issue 7 (9th September 2013) Authors: Milla, Carlos E.; Chmiel, James F.; Accurso, Frank J.; VanDevanter, Donald R.; Konstan, Michael W.; Yarranton, Geoffrey; Geller, David E.; for the KB001 Study Group Journal: Pediatric pulmonology Issue: Volume 49:Issue 7(2014:Jul.) Page Start: 650 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Phase 2, randomised placebo-controlled trial to evaluate the efficacy and safety of an anti-GM-CSF antibody (KB003) in patients with inadequately controlled asthma. Issue 1 (6th January 2016) Authors: Molfino, Nestor A; Kuna, Piotr; Leff, Jonathan A; Oh, Chad K; Singh, Dave; Chernow, Marlene; Sutton, Brian; Yarranton, Geoffrey Journal: BMJ open Issue: Volume 6:Issue 1(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗